Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Narayana Hrudayalaya...

    Narayana Hrudayalaya plans Rs 500 crore expansion,to enter Africa

    Written by Ruby Khatun Khatun Published On 2017-11-20T10:18:58+05:30  |  Updated On 14 Aug 2021 5:53 PM IST

    Mumbai: Leading private sector hospital chain Narayana Hrudayalaya has chalked out a Rs 500 crore expansion plan, which will see it entering high-value markets in the country over next three years as well as making a foray into Africa.


    "After acquiring Health City, Cayman Islands, which is our sole overseas venture so far, we now plan to consolidate our domestic presence by entering the high-value markets like Delhi-NCR and Mumbai. We're also exploring opportunities in Africa," Narayana Hrudayalaya's vice-chairman and managing director Ashutosh Raghuvanshi told here over the weekend.


    He said the domestic expansion will be through a cluster-based approach and the initial focus will be Delhi-NCR.


    For overseas expansion, Raghuvanshi said, they have signed agreements with local partners in the Kenyan capital of Nairobi, for which they have also signed an agreement with an international financial institution for funding. This will be a greenfield project.


    The domestic expansion will be in Delhi-NCR and Narayana will be commissioning a 200-bed hospital in Gurugram in January, he said, adding the capacity will be ramped up to 350 beds over next one-and-a-half years.


    Narayana recently opened its first hospital in Mumbai - the SRCC Children's Hospital, which is the only paediatric hospital in its portfolio. The super-specialty tertiary care for children has already completed 300 surgeries and screened 5,000 children in the outpatient department.


    On investments, Raghuvanshi said, "We're looking at an investment of Rs 500 crore over the next three years. Our focus is on continuously investing and upgrading existing and new hospitals in the country with a capex plan of Rs 100-150 crore per year."


    He said most of the annual capex will be used to improve technology, equipment and supply chains.


    Narayana has invested Rs 55 crore in Mumbai hospital in the first phase and an additional Rs 25 crore will be invested to increase capacity to 380 beds in the second phase, said Raghuvanshi.


    The company had picked up 71 percent stake in Health City Cayman Islands for USD 32 million in 2015. It had a revenue of USD 12 million in the past quarter, he said.


    "We want the existing hospitals to mature but will keenly explore brownfield projects which have interesting growth possibilities," he said.


    Narayana has six focus areas across all its hospitals, Raghuvanshi said, adding that as a result revenue from the cardiac care side has come down from 90 to 40 percent now. While gastro care chips in with 14 percent, 11 percent come from oncology and 10 percent from renal sciences, he added.


    Raghuvanshi said the company will continue to focus on updating technologies on the healthcare delivery side like diagnostic equipment and advanced imaging.


    On the cluster approach, he said, "This approach is inspired by the advantages of sharing technical resources, human resources, and supply chains so that a more profitable growth is achieved at the same time maintain quality, efficiency, transparent pricing."


    Narayana has a dominant presence in Bengaluru, Mysore and Shimoga in Karnataka and also in Kolkata, Jamshedpur, Guwahati and Jaipur.


    It is planning an expansion and upgrade of the Dharamshila Cancer Hospital in east Delhi to a super specialty hospital with 380 beds from the present 250, over the next few years, Raguvanshi said.


    The company also has a hospital each in Bellary in Karnataka and Palanpur in Gujarat on franchisee model, he said.

    AfricaAshutosh RaghuvanshiCayman IslandsenterExpansionHealth Cityhospital indiamarketsNarayana Hrudayalayapaediatric hospitalSRCC Childrens Hospital
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok